Teleflex (TFX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Teleflex Revenue Highlights

Latest Revenue (Y)

$3.05B

Latest Revenue (Q)

$780.89M

Main Segment (Y)

Vascular Access

Main Geography (Y)

UNITED STATES

Teleflex Revenue by Period

Teleflex Revenue by Year

Date	Revenue	Change
2024-12-31	$3.05B	2.45%
2023-12-31	$2.97B	6.57%
2022-12-31	$2.79B	-0.66%
2021-12-31	$2.81B	10.74%
2020-12-31	$2.54B	-2.24%
2019-12-31	$2.60B	6.00%
2018-12-31	$2.45B	14.07%
2017-12-31	$2.15B	14.90%
2016-12-31	$1.87B	3.22%
2015-12-31	$1.81B	-1.64%
2014-12-31	$1.84B	8.46%
2013-12-31	$1.70B	9.37%
2012-12-31	$1.55B	1.45%
2011-12-31	$1.53B	-15.14%
2010-12-31	$1.80B	-4.67%
2009-12-31	$1.89B	-21.93%
2008-12-31	$2.42B	25.16%
2007-12-31	$1.93B	-26.92%
2006-12-31	$2.65B	5.26%
2005-12-25	$2.51B	1.17%
2004-12-26	$2.49B	8.89%
2003-12-28	$2.28B	9.93%
2002-12-29	$2.08B	8.99%
2001-12-31	$1.91B	7.96%
2000-12-31	$1.76B	10.20%
1999-12-26	$1.60B	11.37%
1998-12-27	$1.44B	25.47%
1997-12-28	$1.15B	23.05%
1996-12-29	$931.20M	2.03%
1995-12-31	$912.70M	12.30%
1994-12-25	$812.70M	21.88%
1993-12-26	$666.80M	-

Teleflex generated $3.05B in revenue during NA 2024, up 2.45% compared to the previous quarter, and up 117.41% compared to the same period a year ago.

Teleflex Revenue by Quarter

Date	Revenue	Change
2025-06-29	$780.89M	11.45%
2025-03-30	$700.67M	-11.91%
2024-12-31	$795.41M	4.06%
2024-09-29	$764.38M	1.96%
2024-06-30	$749.69M	1.60%
2024-03-31	$737.85M	-4.66%
2023-12-31	$773.91M	3.69%
2023-10-01	$746.39M	0.42%
2023-07-02	$743.26M	4.55%
2023-04-02	$710.93M	-6.21%
2022-12-31	$758.00M	10.37%
2022-09-25	$686.79M	-2.52%
2022-06-26	$704.54M	9.79%
2022-03-27	$641.72M	-15.78%
2021-12-31	$761.91M	8.81%
2021-09-26	$700.25M	-1.85%
2021-06-27	$713.47M	12.55%
2021-03-28	$633.92M	-10.86%
2020-12-31	$711.18M	13.19%
2020-09-27	$628.30M	10.80%
2020-06-28	$567.03M	-10.09%
2020-03-29	$630.64M	-7.39%
2019-12-31	$680.95M	5.03%
2019-09-29	$648.32M	-0.64%
2019-06-30	$652.51M	6.34%
2019-03-31	$613.58M	-4.37%
2018-12-31	$641.62M	5.24%
2018-09-30	$609.67M	-0.03%
2018-07-01	$609.87M	3.85%
2018-04-01	$587.23M	-1.32%
2017-12-31	$595.11M	11.30%
2017-10-01	$534.70M	1.15%
2017-07-02	$528.61M	8.35%
2017-04-02	$487.88M	-5.07%
2016-12-31	$513.93M	12.79%
2016-09-25	$455.65M	-3.78%
2016-06-26	$473.55M	11.45%
2016-03-27	$424.89M	-12.30%
2015-12-31	$484.50M	9.19%
2015-09-27	$443.71M	-1.84%
2015-06-28	$452.05M	5.27%
2015-03-29	$429.43M	-9.79%
2014-12-31	$476.01M	4.12%
2014-09-28	$457.17M	-2.34%
2014-06-29	$468.11M	6.74%
2014-03-30	$438.55M	-2.66%
2013-12-31	$450.54M	8.88%
2013-09-29	$413.80M	-1.49%
2013-06-30	$420.06M	1.99%
2013-03-31	$411.88M	-1.71%
2012-12-31	$419.06M	13.86%
2012-09-30	$368.05M	-3.99%
2012-07-01	$383.33M	-1.14%
2012-04-01	$387.76M	-5.82%
2011-12-31	$411.73M	10.71%
2011-09-25	$371.89M	-4.96%
2011-06-26	$391.29M	0.68%
2011-03-27	$388.66M	-18.32%
2010-12-31	$475.84M	7.41%
2010-09-26	$442.99M	-4.05%
2010-06-27	$461.68M	5.78%
2010-03-28	$436.46M	-15.25%
2009-12-31	$515.00M	11.60%
2009-09-27	$461.48M	-4.47%
2009-06-28	$483.06M	2.85%
2009-03-29	$469.68M	-21.26%
2008-12-31	$596.46M	0.10%
2008-09-28	$595.88M	-4.52%
2008-06-29	$624.09M	3.24%
2008-03-30	$604.52M	-978.76%
2007-12-31	$-68.79M	-

Teleflex generated $780.89M in revenue during Q2 2025, up 11.45% compared to the previous quarter, and up 105.83% compared to the same period a year ago.

Teleflex Revenue Breakdown

Teleflex Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Surgical	$450.48M	$427.36M	$392.92M	$377.76M	$317.20M
Anesthesia	$395.29M	$389.96M	$388.89M	$380.14M	$302.29M
Interventional Urology	$331.09M	$319.79M	$322.83M	$341.66M	$290.02M
Interventional	$586.06M	$511.43M	$445.02M	$427.50M	$382.44M
Other	$207.22M	$291.90M	$285.15M	$336.58M	$367.26M
Vascular Access	$732.67M	$708.04M	$683.61M	$700.24M	$657.70M
Oem	-	-	$272.62M	$245.68M	$220.25M

Teleflex's latest annual revenue breakdown by segment (product or service), as of Dec 24: Vascular Access (27.11%), Interventional (21.68%), Surgical (16.67%), Anesthesia (14.62%), Interventional Urology (12.25%), and Other (7.67%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Vascular Access	$185.53M	$182.37M	$189.32M	$180.90M	$181.10M	$181.35M	$186.69M	$169.92M	$173.78M	$177.65M	$186.42M	$167.15M	$163.91M	$166.13M	$193.05M	$175.48M	$167.74M	$163.97M	$182.45M	$160.05M
Anesthesia	$96.39M	$86.59M	$95.29M	$101.15M	$102.49M	$96.35M	$98.17M	$97.61M	$100.84M	$93.33M	$99.63M	$97.61M	$104.69M	$86.96M	$102.78M	$97.07M	$95.43M	$84.86M	$86.09M	$75.65M
Interventional Urology	$76.39M	$70.97M	$84.85M	$83.39M	$83.10M	$79.74M	$92.97M	$73.62M	$77.82M	$75.38M	$89.15M	$78.97M	$79.82M	$74.89M	$92.95M	$83.11M	$92.24M	$73.36M	$93.91M	$81.77M
Interventional	$170.02M	$137.56M	$160.37M	$149.87M	$141.16M	$134.66M	$135.67M	$134.09M	$124.78M	$116.90M	$125.08M	$108.74M	$114.34M	$96.86M	$114.94M	$104.30M	$112.08M	$96.17M	$106.73M	$93.19M
Other	$59.85M	$53.51M	$58.24M	$54.76M	$41.70M	$52.52M	$68.26M	$76.03M	$75.95M	$71.65M	$73.59M	$69.91M	$72.14M	$69.51M	$84.68M	$83.38M	$86.84M	$81.68M	$98.10M	$86.02M
Surgical	$114.04M	$105.78M	$121.91M	$111.75M	$111.30M	$105.52M	$109.58M	$112.81M	$105.95M	$99.02M	$110.45M	$93.12M	$99.64M	$89.70M	$106.35M	$92.83M	$98.19M	$80.39M	$92.27M	$82.22M
Oem	-	-	-	-	-	$87.70M	$82.31M	$84.13M	$77.00M	$73.68M	$71.29M	$70.00M	$57.66M	$67.15M	$64.08M	$60.96M	$53.49M	$51.63M	-	-

Teleflex's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Vascular Access (26.42%), Interventional (24.21%), Surgical (16.24%), Anesthesia (13.73%), Interventional Urology (10.88%), and Other (8.52%).

Teleflex Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
EMEA	$705.09M	$586.25M	-	-	-
Asia	$326.37M	$346.90M	-	-	-
UNITED STATES	$1.89B	$1.79B	$1.77B	$1.57B	-
Oem	-	$326.01M	-	-	-
EMEA Segment	-	$586.25M	-	-	-
Asia Segment	-	$346.90M	-	-	-
Americas Segment	-	$1.72B	-	-	-
Asia And Asia Pacific	-	-	$270.75M	$263.02M	$230.27M
Europe	-	-	$622.34M	$665.00M	$646.58M
All Other	-	-	$111.48M	$112.05M	$93.17M

Teleflex's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (64.69%), EMEA (24.14%), and Asia (11.17%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Oct 23	Jul 23	Apr 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Dec 19
EMEA	$166.23M	$151.16M	$248.15M	$150.22M	$147.06M	$159.66M	$135.65M	$131.64M	$156.12M	$145.93M	-	-	-	-	-	-	-	-	-	-
Asia	$89.03M	$73.79M	$56.90M	$98.26M	$87.00M	$84.21M	$68.21M	$67.07M	$53.13M	$80.46M	-	-	-	-	-	-	-	-	-	-
Americas Segment	$525.64M	$475.72M	$433.33M	$426.81M	$406.29M	$450.62M	$428.21M	$424.64M	$411.86M	$405.04M	$412.74M	$377.96M	$417.33M	$414.79M	$375.49M	-	-	-	-	-
Oem	-	-	-	$82.56M	$88.83M	$87.70M	$49.40M	$55.83M	$63.39M	$54.61M	-	-	-	-	-	-	-	-	-	-
EMEA Segment	-	-	-	-	-	$159.66M	$152.37M	$142.72M	$147.81M	$143.34M	$128.44M	$145.19M	$136.91M	$143.88M	$157.13M	$141.25M	-	-	-	-
Asia Segment	-	-	-	-	-	$84.21M	$88.34M	$93.15M	$86.68M	$78.73M	$82.03M	$76.61M	$69.19M	$74.96M	$80.60M	$63.69M	-	-	-	-
OEM Segment	-	-	-	-	-	$87.70M	$82.31M	$84.13M	$77.00M	$71.29M	$70.00M	$57.66M	$64.08M	$60.96M	$53.49M	-	-	-	-	-
Vascular North America	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$375.04M	$312.49M	$358.00M	$399.95M

Teleflex's latest quarterly revenue breakdown by geography, as of Jun 25: Americas Segment (67.31%), EMEA (21.29%), and Asia (11.40%).

Teleflex Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BTSG	BrightSpring Health Services	$11.27B	$3.33B
OSCR	Oscar Health	$9.18B	$2.86B
BLCO	Bausch + Lomb	$4.77B	$1.27B
BRKR	Bruker	$3.37B	$797.40M
TFX	Teleflex	$3.05B	$780.89M
ALKS	Alkermes	$1.56B	$394.19M
MMSI	Merit Medical Systems	$1.30B	$382.46M
STVN	Stevanato Group S.p.A.	$1.06B	$237.38M
PTCT	PTC Therapeutics	$806.78M	$1.18B
KRYS	Krystal Biotech	$290.51M	$96.04M
TGTX	TG Therapeutics	-	$141.15M

TFX Revenue FAQ

What is Teleflex’s yearly revenue?

Teleflex's yearly revenue for 2024 was $3.05B, representing an increase of 2.45% compared to 2023. The company's yearly revenue for 2023 was $2.97B, representing an increase of 6.57% compared to 2022. TFX's yearly revenue for 2022 was $2.79B, representing a decrease of -0.66% compared to 2021.

What is Teleflex’s quarterly revenue?

Teleflex's quarterly revenue for Q2 2025 was $780.89M, a 11.45% increase from the previous quarter (Q1 2025), and a 4.16% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $700.67M, a -11.91% decrease from the previous quarter (Q4 2024), and a -5.04% decrease year-over-year (Q1 2024). TFX's quarterly revenue for Q4 2024 was $795.41M, a 4.06% increase from the previous quarter (Q3 2024), and a 2.78% increase year-over-year (Q4 2023).

What is Teleflex’s revenue growth rate?

Teleflex's revenue growth rate for the last 3 years (2022-2024) was 9.18%, and for the last 5 years (2020-2024) was 20.11%.

What are Teleflex’s revenue streams?

Teleflex's revenue streams in c 24 are Surgical, Anesthesia, Interventional Urology, Interventional, Other, and Vascular Access. Surgical generated $450.48M in revenue, accounting 16.67% of the company's total revenue, up 5.41% year-over-year. Anesthesia generated $395.28M in revenue, accounting 14.62% of the company's total revenue, up 1.37% year-over-year. Interventional Urology generated $331.09M in revenue, accounting 12.25% of the company's total revenue, up 3.54% year-over-year. Interventional generated $586.06M in revenue, accounting 21.68% of the company's total revenue, up 14.59% year-over-year. Other generated $207.22M in revenue, accounting 7.67% of the company's total revenue, down -29.01% year-over-year. Vascular Access generated $732.68M in revenue, accounting 27.11% of the company's total revenue, up 3.48% year-over-year.

What is Teleflex’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Teleflex was Vascular Access. This segment made a revenue of $732.68M, representing 27.11% of the company's total revenue.